A Study to Investigate the Safety and Pharmacokinetics of a Single Dose of VH3810109 (Also Known as GSK3810109), Administered Either Subcutaneously (SC) With rHuPH20 or Intravenously (IV), in Healthy Adult Participants
Clinical trial NCT05291520 · COMPLETED
Trial details
- NCT number
- NCT05291520
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-23
- Primary completion
- 2023-04-10
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.